{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:54:44Z","timestamp":1776779684060,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006010","name":"Bayer Schering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015739","name":"Bayer Vital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Charit\u00e9 Research Organisation GmbH"},{"name":"Abbot"},{"name":"BRACCO Group"},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Essex Pharma"},{"DOI":"10.13039\/100020333","name":"Guerbet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020333","id-type":"DOI","asserted-by":"crossref"}]},{"name":"INC Research"},{"name":"InSightec Ud"},{"DOI":"10.13039\/501100014382","name":"IPSEN Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kendlel MorphoSys AG"},{"name":"Lilly GmbH"},{"name":"MeVis Medical Solutions AG"},{"name":"Nexus Oncology"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Parexel Clinical Research Organisation Service"},{"name":"Pfizer GmbH"},{"name":"Philipps"},{"name":"Sanofis-Aventis"},{"name":"Siemens"},{"name":"Teruma Medical Corporation"},{"name":"Toshiba"},{"name":"Zukunfsfond Berlin"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001702","name":"AO Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001702","id-type":"DOI","asserted-by":"crossref"}]},{"name":"BARD"},{"name":"BBraun"},{"name":"Boehring Ingelheimer"},{"name":"Brainsgate"},{"name":"CELLACT Pharma"},{"name":"CeloNova Bio-Sciences"},{"DOI":"10.13039\/100005620","name":"North Carolina GlaxoSmithKline Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005620","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jansen"},{"name":"Roehe"},{"name":"Sehumaeher GmbH"},{"name":"Medtronic"},{"name":"Pluristem"},{"name":"Quintiles"},{"name":"Astellas"},{"name":"Chiltern"},{"DOI":"10.13039\/100019040","name":"Respicardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"TEVA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"name":"Galmed Research and Development"},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>18F-FDG-PET\/CT is standard to assess response in Hodgkin lymphoma by quantifying metabolic activity with the Deauville score. PET\/CT, however, is time-consuming, cost-extensive, linked to high radiation and has a low availability. As an alternative, we investigated radiomics from non-contrast-enhanced computed tomography (NECT) scans. 75 PET\/CT examinations of 43 patients on two different scanners were included. Target lesions were classified as Deauville score 4 positive (DS4+) or negative (DS4\u2212) based on their SUVpeak and then segmented in NECT images. From these segmentations, 107 features were extracted with PyRadiomics. All further statistical analyses were then performed scanner-wise: differences between DS4+ and DS4\u2212 manifestations were assessed with the Mann\u2013Whitney-U-test and single feature performances with the ROC-analysis. To further verify the reliability of the results, the number of features was reduced using different techniques. The feature median showed a high sensitivity for DS4+ manifestations on both scanners (scanner A: 0.91, scanner B: 0.85). It furthermore was the only feature that remained in both datasets after applying different feature reduction techniques. The feature median from NECT concordantly has a high sensitivity for DS4+ Hodgkin manifestations on two different scanners and thus could provide a surrogate for increased metabolic activity in PET\/CT.<\/jats:p>","DOI":"10.1038\/s41598-022-24227-0","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T04:32:15Z","timestamp":1669091535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-5733","authenticated-orcid":false,"given":"Laura J.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0817-6532","authenticated-orcid":false,"given":"Julian M. M.","family":"Rogasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3145-7559","authenticated-orcid":false,"given":"Damon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Rie\u00dfelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-7886","authenticated-orcid":false,"given":"Christian","family":"Furth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4414-0657","authenticated-orcid":false,"given":"Holger","family":"Amthauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-027X","authenticated-orcid":false,"given":"Bernd","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2059-4275","authenticated-orcid":false,"given":"Ingo G.","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7155-6044","authenticated-orcid":false,"given":"Thomas","family":"Elgeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-2913","authenticated-orcid":false,"given":"Sebastian N.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"24227_CR1","doi-asserted-by":"publisher","unstructured":"Cheson, B. D. PET\/CT in Lymphoma: Current overview and future directions. Semin. Nucl. Med. 48, 76\u201381. https:\/\/doi.org\/10.1053\/j.semnuclmed.2017.09.007 (2018).","DOI":"10.1053\/j.semnuclmed.2017.09.007"},{"key":"24227_CR2","doi-asserted-by":"publisher","unstructured":"Bertuzzi, C., Sabattini, E. & Agostinelli, C. Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13143634 (2021).","DOI":"10.3390\/cancers13143634"},{"key":"24227_CR3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1182\/blood-2018-05-852129","volume":"132","author":"C Kobe","year":"2018","unstructured":"Kobe, C. et al. Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma. Blood 132, 2273\u20132279. https:\/\/doi.org\/10.1182\/blood-2018-05-852129 (2018).","journal-title":"Blood"},{"key":"24227_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan, M., Gallamini, A., Meignan, M., Gallamini, A. & Haioun, C. Report on the first international workshop on interim-PET-scan in lymphoma. Leuk. Lymphoma 50, 1257\u20131260. https:\/\/doi.org\/10.1080\/10428190903040048 (2009).","journal-title":"Leuk. Lymphoma"},{"key":"24227_CR5","doi-asserted-by":"publisher","unstructured":"Barrington, S. F. et al. Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J. Clin. Oncol. 32, 3048\u20133058. https:\/\/doi.org\/10.1200\/JCO.2013.53.5229 (2014).","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"24227_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson, B. D. et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J. Clin. Oncol. 32, 3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800 (2014).","journal-title":"J. Clin. Oncol."},{"key":"24227_CR7","first-page":"7924","volume":"120","author":"R Kluge","year":"2020","unstructured":"Kluge, R. et al. Comparison of interim PET response to second-line vs to first-line treatment in classical Hodgkin lymphoma\u2013contribution to the development of response criteria for relapsed or progressive disease. J.Nucl. Med. 120, 7924 (2020).","journal-title":"J.Nucl. Med."},{"key":"24227_CR8","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1038\/s41598-020-68310-w","volume":"10","author":"GY Song","year":"2020","unstructured":"Song, G. Y. et al. Prognostic significance of interim PET\/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era. Sci. Rep. 10, 11649. https:\/\/doi.org\/10.1038\/s41598-020-68310-w (2020).","journal-title":"Sci. Rep."},{"key":"24227_CR9","doi-asserted-by":"publisher","first-page":"121904","DOI":"10.1118\/1.4900821","volume":"41","author":"T Knogler","year":"2014","unstructured":"Knogler, T., El-Rabadi, K., Weber, M., Karanikas, G. & Mayerhoefer, M. E. Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: Comparison with F-18-FDG PET. Med. Phys. 41, 121904. https:\/\/doi.org\/10.1118\/1.4900821 (2014).","journal-title":"Med. Phys."},{"key":"24227_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymeth.2020.05.022","volume":"188","author":"A Ibrahim","year":"2021","unstructured":"Ibrahim, A. et al. Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework. Methods 188, 20\u201329. https:\/\/doi.org\/10.1016\/j.ymeth.2020.05.022 (2021).","journal-title":"Methods"},{"key":"24227_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin, P. et al. Radiomics: The bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 14, 749\u2013762. https:\/\/doi.org\/10.1038\/nrclinonc.2017.141 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"24227_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymeth.2020.06.020","volume":"188","author":"ME Mayerhoefer","year":"2021","unstructured":"Mayerhoefer, M. E., Umutlu, L. & Schoder, H. Functional imaging using radiomic features in assessment of lymphoma. Methods 188, 105\u2013111. https:\/\/doi.org\/10.1016\/j.ymeth.2020.06.020 (2021).","journal-title":"Methods"},{"key":"24227_CR13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41598-018-37197-z","volume":"9","author":"SA Milgrom","year":"2019","unstructured":"Milgrom, S. A. et al. A PET radiomics model to predict refractory Mediastinal Hodgkin lymphoma. Sci. Rep. 9, 1322. https:\/\/doi.org\/10.1038\/s41598-018-37197-z (2019).","journal-title":"Sci. Rep."},{"key":"24227_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00330-016-4470-8","volume":"27","author":"B Ganeshan","year":"2017","unstructured":"Ganeshan, B. et al. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin\u2019s and aggressive non-hodgkin\u2019s lymphomas. Eur. Radiol. 27, 1012\u20131020. https:\/\/doi.org\/10.1007\/s00330-016-4470-8 (2017).","journal-title":"Eur. Radiol."},{"key":"24227_CR15","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1097\/RLU.0000000000002732","volume":"44","author":"KH Lue","year":"2019","unstructured":"Lue, K. H. et al. Prognostic value of pretreatment radiomic features of 18F-FDG PET in patients with hodgkin lymphoma. Clin. Nucl. Med. 44, e559\u2013e565. https:\/\/doi.org\/10.1097\/RLU.0000000000002732 (2019).","journal-title":"Clin. Nucl. Med."},{"key":"24227_CR16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1038\/s41598-021-81526-8","volume":"11","author":"AK Jha","year":"2021","unstructured":"Jha, A. K. et al. Repeatability and reproducibility study of radiomic features on a phantom and human cohort. Sci. Rep. 11, 2055. https:\/\/doi.org\/10.1038\/s41598-021-81526-8 (2021).","journal-title":"Sci. Rep."},{"key":"24227_CR17","doi-asserted-by":"publisher","first-page":"23428","DOI":"10.1038\/srep23428","volume":"6","author":"B Zhao","year":"2016","unstructured":"Zhao, B. et al. Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci. Rep. 6, 23428. https:\/\/doi.org\/10.1038\/srep23428 (2016).","journal-title":"Sci. Rep."},{"key":"24227_CR18","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.1038\/s41598-018-31509-z","volume":"8","author":"RB Ger","year":"2018","unstructured":"Ger, R. B. et al. Comprehensive investigation on controlling for ct imaging variabilities in radiomics studies. Sci Rep 8, 13047. https:\/\/doi.org\/10.1038\/s41598-018-31509-z (2018).","journal-title":"Sci Rep"},{"key":"24227_CR19","first-page":"471","volume":"48","author":"S Surti","year":"2007","unstructured":"Surti, S. et al. Performance of Philips Gemini TF PET\/CT scanner with special consideration for its time-of-flight imaging capabilities. J. Nucl. Med. 48, 471\u2013480 (2007).","journal-title":"J. Nucl. Med."},{"key":"24227_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40658-019-0244-0","volume":"6","author":"D Vandendriessche","year":"2019","unstructured":"Vandendriessche, D., Uribe, J., Bertin, H. & De Geeter, F. Performance characteristics of silicon photomultiplier based 15-cm AFOV TOF PET\/CT. EJNMMI Phys. 6, 8. https:\/\/doi.org\/10.1186\/s40658-019-0244-0 (2019).","journal-title":"EJNMMI Phys."},{"key":"24227_CR21","doi-asserted-by":"publisher","unstructured":"Rogasch, J. M. et al. Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF). EJNMMI Phys 7, 2. https:\/\/doi.org\/10.1186\/s40658-020-0270-y (2020).","DOI":"10.1186\/s40658-020-0270-y"},{"key":"24227_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov, A. et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn. Reson. Imaging 30, 1323\u20131341. https:\/\/doi.org\/10.1016\/j.mri.2012.05.001 (2012).","journal-title":"Magn. Reson. Imaging"},{"key":"24227_CR23","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","volume":"41","author":"D Hasenclever","year":"2014","unstructured":"Hasenclever, D. et al. qPET\u2014a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur. J. Nucl. Med. Mol. Imaging 41, 1301\u20131308. https:\/\/doi.org\/10.1007\/s00259-014-2715-9 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"24227_CR24","unstructured":"Fedorov, A. PET indiC tool. https:\/\/qiicr.org\/tool\/PETIndiC\/ (2018)."},{"key":"24227_CR25","unstructured":"PyRadiomics community. Radiomic features. https:\/\/pyradiomics.readthedocs.io\/en\/latest\/features.html (2016)."},{"key":"24227_CR26","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0339 (2017).","journal-title":"Cancer Res."},{"key":"24227_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg, A. et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295, 328\u2013338. https:\/\/doi.org\/10.1148\/radiol.2020191145 (2020).","journal-title":"Radiology"},{"key":"24227_CR28","unstructured":"R: A language and environment for statistical computing (R Foundation for Statistical Computing, Vienna, Austria, 2016)."},{"key":"24227_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf. 12, 77. https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","journal-title":"BMC Bioinf."},{"key":"24227_CR30","doi-asserted-by":"crossref","unstructured":"Hosmer Jr, D. W., Lemeshow, S. & Sturdivant, R. X. Applied logistic regression. Vol. 398 (John Wiley & Sons, 2013).","DOI":"10.1002\/9781118548387"},{"key":"24227_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout, P. E. & Fleiss, J. L. Intraclass correlations: Uses in assessing rater reliability. Psychol. Bull. 86, 420\u2013428. https:\/\/doi.org\/10.1037\/\/0033-2909.86.2.420 (1979).","journal-title":"Psychol. Bull."},{"key":"24227_CR32","unstructured":"Revelle, W. psych: Procedures for Psychological, Psychometric, and Personality Research. Northwestern University, Evanston, Illinois. R package version 2.2.9 (2022). https:\/\/CRAN.R-project.org\/package=psych."},{"key":"24227_CR33","unstructured":"Harell, F. Jr. Hmisc: Harrell Miscellaneous. R package version 4.7\u20131. https:\/\/CRAN.R-project.org\/package=Hmisc (2022)."},{"key":"24227_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2021.100819","volume":"16","author":"MB Kursa","year":"2022","unstructured":"Kursa, M. B. Praznik: High performance information-based feature selection\u201d. SoftwareX 16, 100819. https:\/\/doi.org\/10.1016\/j.softx.2021.100819 (2022).","journal-title":"SoftwareX"},{"key":"24227_CR35","unstructured":"Kuhn, M. caret: Classification and Regression Training. R package version 6.0\u201393. https:\/\/CRAN.R-project.org\/package=caret (2022)."},{"key":"24227_CR36","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1080\/10428194.2020.1786555","volume":"61","author":"SH Desai","year":"2020","unstructured":"Desai, S. H., Al-Shbool, G., Desale, S., Veis, J. & Malkovska, V. Lymphoma survivors have an increased long-term risk of chronic kidney disease. Leuk. Lymphoma 61, 2923\u20132930. https:\/\/doi.org\/10.1080\/10428194.2020.1786555 (2020).","journal-title":"Leuk. Lymphoma"},{"key":"24227_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1148\/radiol.2018172361","volume":"288","author":"R Berenguer","year":"2018","unstructured":"Berenguer, R. et al. Radiomics of CT features may be nonreproducible and redundant: Influence of CT acquisition parameters. Radiology 288, 407\u2013415. https:\/\/doi.org\/10.1148\/radiol.2018172361 (2018).","journal-title":"Radiology"},{"key":"24227_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05233-2","author":"R Frood","year":"2021","unstructured":"Frood, R. et al. Baseline PET\/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: A systematic review. Eur. J. Nucl. Med. Mol. Imaging https:\/\/doi.org\/10.1007\/s00259-021-05233-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"24227_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2967\/jnumed.116.179648","volume":"58","author":"FL Giesel","year":"2017","unstructured":"Giesel, F. L. et al. Correlation between SUVmax and CT radiomic analysis using lymph node density in PET\/CT-based lymph node staging. J. Nucl. Med. 58, 282\u2013287. https:\/\/doi.org\/10.2967\/jnumed.116.179648 (2017).","journal-title":"J. Nucl. Med."},{"key":"24227_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11307-017-1155-x","volume":"20","author":"P Flechsig","year":"2018","unstructured":"Flechsig, P. et al. Role of CT density in PET\/CT-based assessment of lymphoma. Mol. Imaging Biol. 20, 641\u2013649. https:\/\/doi.org\/10.1007\/s11307-017-1155-x (2018).","journal-title":"Mol. Imaging Biol."},{"key":"24227_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5152\/dir.2015.15220","volume":"22","author":"P Flechsig","year":"2016","unstructured":"Flechsig, P. et al. Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer. Diagn. Interv. Radiol. 22, 35\u201339. https:\/\/doi.org\/10.5152\/dir.2015.15220 (2016).","journal-title":"Diagn. Interv. Radiol."},{"key":"24227_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-022-01703-7","author":"H Jiang","year":"2022","unstructured":"Jiang, H., Li, A., Ji, Z., Tian, M. & Zhang, H. Role of radiomics-based baseline PET\/CT imaging in lymphoma: diagnosis, prognosis, and response assessment. Mol. Imaging Biol. https:\/\/doi.org\/10.1007\/s11307-022-01703-7 (2022).","journal-title":"Mol. Imaging Biol."},{"key":"24227_CR43","doi-asserted-by":"publisher","first-page":"23812","DOI":"10.1038\/s41598-021-03278-9","volume":"11","author":"J Faudemer","year":"2021","unstructured":"Faudemer, J. et al. Diagnostic value of baseline (18)FDG PET\/CT skeletal textural features in follicular lymphoma. Sci. Rep. 11, 23812. https:\/\/doi.org\/10.1038\/s41598-021-03278-9 (2021).","journal-title":"Sci. Rep."},{"key":"24227_CR44","doi-asserted-by":"publisher","first-page":"10192","DOI":"10.1038\/s41598-022-13967-8","volume":"12","author":"I Shahzadi","year":"2022","unstructured":"Shahzadi, I. et al. Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Sci. Rep. 12, 10192. https:\/\/doi.org\/10.1038\/s41598-022-13967-8 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24227-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T15:03:54Z","timestamp":1669129434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24227-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24227-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"10 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20008"}}